Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature

[1]  Asim Khwaja,et al.  Acute myeloid leukaemia , 2016, Nature Reviews Disease Primers.

[2]  F. Robert,et al.  GFI1 as a novel prognostic and therapeutic factor for AML/MDS , 2016, Leukemia.

[3]  W. D. Pozzo,et al.  University of Birmingham Regulation of the Flt3 gene in haematopoietic stem and early progenitor cells , 2015 .

[4]  Salam A. Assi,et al.  Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature , 2015, Cell reports.

[5]  W. Paul,et al.  Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia. , 2013, Cancer cell.

[6]  W. D. Pozzo,et al.  C/EBPα and MYB regulate FLT3 expression in AML , 2013, Leukemia.

[7]  E. Diamanti,et al.  The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice. , 2012, Blood.

[8]  Nicola K. Wilson,et al.  GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothelium during hematopoietic commitment. , 2012, Blood.

[9]  D. Lipka,et al.  FLT3 as a therapeutic target in AML: still challenging after all these years. , 2010, Blood.

[10]  Aleksandar Dakic,et al.  The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. , 2010, Immunity.

[11]  L. Bullinger,et al.  Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways , 2010, Leukemia.

[12]  Bob Löwenberg,et al.  Review Articles (434 articles) , 2008 .

[13]  C. Bloomfield,et al.  A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia. , 2007, Blood.

[14]  D. Lipka,et al.  FLT 3 as a therapeutic target in AML : still challenging after all these years , 2010 .

[15]  W. Tse,et al.  Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics , 2009, Journal of hematology & oncology.

[16]  W. Paul,et al.  Gfi1 integrates progenitor versus granulocytic transcriptional programming. , 2009, Blood.

[17]  T. Möröy,et al.  Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia , 2009, International journal of hematology.

[18]  Tina N. Davis,et al.  HOXA9 is required for survival in human MLL-rearranged acute leukemias. , 2009, Blood.

[19]  Bas J. Wouters,et al.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling , 2009, Haematologica.

[20]  T. Möröy,et al.  Gfi1b:green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1. , 2007, Blood.

[21]  G. Wang,et al.  Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. , 2005, Blood.

[22]  S. Orkin,et al.  Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells , 2004, Nature.

[23]  M. Cleary,et al.  Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. , 2003, Genes & development.

[24]  George Eliopoulos,et al.  Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2 , 2003, Nature Genetics.

[25]  J. Griffin,et al.  The roles of FLT3 in hematopoiesis and leukemia. , 2002, Blood.

[26]  T. Möröy,et al.  High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells , 2002, Oncogene.

[27]  D. Gilliland,et al.  FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model. , 2002, Blood.

[28]  Thorsten Schmidt,et al.  Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis , 1998, Oncogene.

[29]  H. Drexler,et al.  Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. , 1996, Leukemia.

[30]  D. Birnbaum,et al.  Expression and signal transduction of the FLT3 tyrosine kinase receptor. , 1996, Acta haematologica.